Early detection and treatment of neovascular age-related macular degeneration

Journal of the American Board of Family Practice

Volumn 15, Issue 2, 2002, Pages 142-152

  Bressler, Neil M ^a,b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b Novartis Ophthalmics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOPORPHYRIN DERIVATIVE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUSEN; EARLY DIAGNOSIS; EXTRAVASATION; HUMAN; INJECTION SITE; LASER COAGULATION; MEDLINE; OPHTHALMOSCOPY; PATIENT EDUCATION; PATIENT REFERRAL; PHOTODYNAMIC THERAPY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RETINA INJURY; RETINA MACULA AGE RELATED DEGENERATION; RISK FACTOR; SUBRETINAL NEOVASCULARIZATION; VISUAL DISORDER; VISUAL FIELD DEFECT; VISUAL IMPAIRMENT;

AGED; FEMALE; HUMANS; LASER SURGERY; MACULAR DEGENERATION; MALE; MIDDLE AGED; PATIENT EDUCATION; PHOTOSENSITIZING AGENTS; PORPHYRINS; PRIMARY HEALTH CARE; REFERRAL AND CONSULTATION; RETINAL NEOVASCULARIZATION; RISK FACTORS;

EID: 0036232006     PISSN: 08938652     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Epidemiology of age-related maculopathy
2. The dimensions of the problem of eye disease among the elderly
3. Age-related macular degeneration: What can a family physician do?
4. Age-related macular degeneration and blindness due to neovascular maculopathy
5. Epidemiology of AMD
6. Age-related macular degeneration and risk factors for the development of choroidal neovascularization in the fellow eye
7. Risk factors for neovascular age-related macular degeneration
8. A prospective study of cigarette smoking and age-related macular degeneration in women
9. The relationship between nutritional factors and age-related macular degeneration
10. Risk factors for choroidal neovascularization in the second eye of patients with juxtafoveal or subfoveal choroidal neovascularization secondary to age-related macular degeneration
11. Visual symptoms associated with choroidal neovascularization. Photopsias and the Charles Bonnet syndrome
12. The early natural history of subfoveal neovascular membranes in eyes with age-related macular degeneration
13. Age-related macular degeneration: How science is improving clinical care. Interview by Marc E. Weksler
14. Natural course of choroidal neovascular membranes within the foveal avascular zone in senile macular degeneration
15. Five-year follow-up of fellow eyes of patients with age-related macular degeneration and unilateral extrafoveal choroidal neovascularization
16. The health-related quality-of-life impact of late-stage age-related macular degeneration
17. The psychosocial impact of macular degeneration
18. Visual impairment and falls in older adults: The Blue Mountains Eye study
19. Age-related macular degeneration
20. Subfoveal neovascular lesions in age-related macular degeneration. Guidelines for evaluation and treatment in the Macular Photocoagulation study
21. Clinical characteristics of choroidal neovascular membranes
22. Argon laser photocoagulation for neovascular maculopathy. Five-year results from randomized clinical trials
23. Krypton laser photocoagulation for neovascular lesions of age-related macular degeneration. Results of a randomized clinical trial
24. Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial
25. Age-related macular degeneration: A review of experimental treatments
26. Persistent and recurrent neovascularization after krypton laser photocoagulation for neovascular lesions of age-related macular degeneration
27. Persistent and recurrent neovascularization after laser photocoagulation for subfoveal choroidal neovascularization of age-related macular degeneration
28. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. One-year results of 2 randomized clinical trials - TAP Report 1
29. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. Two-year results of 2 randomized clinical trials - TAP report 2
30. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: Two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization - Verteporfin in photodynamic therapy report 2
31. Clinical pharmacokinetics of verteporfin in healthy volunteers and patients with CNV
32. Visual outcome after laser photocoagulation for subfoveal choroidal neovascularization secondary to age-related macular degeneration. The influence of initial lesion size and initial visual acuity
33. How effective is undergraduate and postgraduate teaching in ophthalmology?
34. Improved detection and referral of patients with diabetic retinopathy by primary care physicians. Effectiveness of education
35. Age-related vision changes: A primary care guide
36. Detection and prevention of treatable visual failure in general practice: Room for improvement?
37. Referral patterns to an ophthalmic outpatient clinic by general practitioners and ophthalmic opticians and the role of these professionals in screening for ocular disease
38. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss
39. Opportunistic screening of visual acuity of elderly patients attending outpatient clinics
40. Vision screening in a primary care setting. A missed opportunity?
41. Early detection of extrafoveal neovascular membranes by daily central field evaluation
42. Vision loss in age-related maculopathy: Primary care referral guide
43. Knowledge and beliefs about common eye diseases